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INTRODUCTION
The word monitor has a variety of meanings, depending
on the context. A monitor can be any device for checking on
or regulating the performance of a machine, aircraft, or a
patient. A patient monitor is usually thought of as some-
thing that watches, warns, or cautions if there is a life-
threatening event. A more rigorous definition of patient
monitoring is Repeated or continuous observations or
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measurements of the patient, his or her physiological
status, and the functions of life support equipment for
the purpose of guiding management decisions, including
when to make therapeutic interventions and assessment
of those interventions (1). As a result, a monitor should
not only alert physicians and nurses to potentially life-
threatening events, but perhaps should also control
devices that maintain life. The primary emphasis of this
section deals with hemodynamic monitoring of the criti-
cally ill patient who is in an intensive care unit (ICU), but
many of the principles apply to all hospitalized patients.
Hemodynamic monitoring relates to monitoring of the
blood pressure and blood flow in the cardiovascular system.
The cardiovascular system consists of the heart, lungs, and
blood vessels, and has a most important function in main-
taining life in complex animals, such as humans. Oxygen
and fuel must be transported from their source to the
individual cells that consume them. The resulting waste
products of metabolism must then be disposed of. Thus, the
heart and blood vessels transport nutrients to the body and
remove the waste products. Clearly, if this system does not
function properly, the organism could be compromised. As
a consequence clinically applicable methods have been
developed to assess the function of the cardiovascular
system. Hemodynamic monitoring is one part of this com-
plex monitoring strategy. Typical parameters measured
when performing hemodynamic monitoring are heart rate
and rhythm, measured through analysis of the electrocar-
diogram (ECG), blood pressure measurements in various
locations in the cardiovascular system, and estimates of
blood flow usually using cardiac output as a measure.
THEORY
Hemodynamic monitoring permits minute-to-minute
surveillance of the cardiovascular system and provides
physiologic data to assist in diagnosis as well as to guide
therapy (2–5). The cardiovascular system consists of the
heart, lungs, and blood vessels that supply blood to the
body and return blood from the peripheral tissue.
It is beyond the scope of this section to describe the
detailed anatomy of the cardiovascular system. However,
to understand the principles of hemodynamic monitoring
knowledge of the functional aspects of the cardiovascular
system is essential.
HEART
The heart is made up of four chambers: the right atrium
and the right ventricle and the left atrium and the left
ventricle (see Fig. 1). The right atrium accepts blood from
the systemic circulation (head, arms, and legs) via the
superior and inferior vena cava. On atrial contraction
the tricuspid valve between the right atrium and right
ventricle opens and blood flows into the right ventricle. On
ventricular contraction the right ventricle pumps blood
through the pulmonic valve into the pulmonary artery
and to the lungs where oxygen is added and carbon dioxide
is removed. Blood flows from the lungs to the pulmonary
veins and then into the left atrium. On atrial contraction
the blood flows into the left ventricle through the mitral
valve. On ventricular contraction the left ventricle pumps
blood through the aortic valve to the systemic circulation
(aorta and the systemic vasculature).
The basic contractile element of the heart is the sarco-
mere, which is composed of myofilaments, contractile pro-
teins that interdigitate and slide along one another during
contraction. Shortening of the sarcomere is the functional
unit of heart contraction. Physiologic and pharmacologic
agents can change the contractile characteristics of the
sarcomeres. Rate and contractility of the heart are con-
trolled by sympathetic and parasympathetic innervation,
as well as circulating catecholamines.
Control of Heart Performance
Mechanisms regulating cardiac (heart) output involve not
only factors controlling performance of the heart as a
pump, but also factors affecting the systemic vascular
system and its resistance. Typically, the heart can increase
its output to a level of almost five times its resting value.
There are two methods by which the heart regulates its
cardiac output in response to stress, injury, or disease: by
changing heart rate and stroke volume.
Heart Rate Control
Heart rate can be changed rapidly and is thus one of the
most effective ways for the heart to change its cardiac
output. For a healthy person, an increase in heart rate
can more than double the cardiac output when the heart
rate increases to near 180 beats 
min1. However, if a
patient with heart disease increases their heart rate to
>120 beats 
min1 they may have deleterious responses
because of the increased demand for oxygen by the heart
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Figure 1. Outline drawing of the heart with its chambers and
typical pressures (expressed in mmHg) for each area of the heart.
Note the pressures are systolic (SP), diastolic (DP), and mean
(MP), as shown on the arterial pressure waveform.
during diastole (the relaxation phase of heart contraction).
Increasing heart rate decreases the time for cardiac circu-
lation during diastole. In normal subjects, decreasing the
heart rate to  50 beats 
min1 may not decrease cardiac
output because there is increased diastolic filling time that
increases stroke volume.
Stroke Volume Changes
The stroke volume of an intact ventricle is influenced by (1)
ventricular end-diastolic volume (called preload), (2) ven-
tricular afterload, and (3) contractility.
Preload. Preload is the term used to define the end-
diastolic stress in the wall of the ventricle. For example, zero
preload would result in the ventricle ejecting no blood. How-
ever, with increased preload, ventricular ejection generally
increases linearly until the capacity of the pump (heart) is
exceeded. Since the end-diastolic volume so profoundly
influences themyocardialfiber length ithasa great influence
on the myocardial performance. The Frank–Starling law
describes this principle and is illustrated graphically in
Fig. 2. The most accessible measure of right ventricular
preload is the right atrial pressure. Left atrial pressure is
used to estimate left ventricular preload. Since the left
ventricle does most of the work of the heart, it is usually
the first part of the heart muscle to fail. Consequently, the
measurement or estimation of the left atrial pressure is
important in assessing a patient’s hemodynamic status.
Afterload. Afterload is a measure of the impedance
(resistance) against which the right or left ventricles must
eject blood. Resistance (R) is calculated by measuring blood
flow and pressure and then using Ohm’s law {Eq. 1}.




Blood flow to the periphery of the body is controlled by local
autoregulation and by the autonomic nervous system.
Local autoregulation of blood flow helps tissue meet its
oxygen requirements. For example, with decreased blood
flow, metabolic byproducts increase, causing local vasodi-
latation that tends to increase blood flow. There are bar-
oreceptors, similar to blood pressure transducers, located
in the aortic arch and the carotid sinus which sense blood
pressure. Via the baroreceptor reflex mechanism, the body
regulates the blood pressure. In addition, chemoreceptors
in the carotid sinus and other locations regulate respira-
tion by responding to changes in CO2 and O2.
Pulmonary Circulation
The pulmonary arterial vessels differ markedly from sys-
temic arterial vessels; they have thinner walls, less muscle,
and have a resistance to blood flow about one-sixth that of
the systemic circulation.
Contractility. Contractility is a measure of how a
healthy heart performs. A healthy heart pumps vigorously
and nearly empties its ventricles with each beat and is said
to have excellent contractility. On the other hand, a com-
promised heart may not be able to empty effectively.
HEMODYNAMIC MONITORING
Bedside hemodynamic monitoring makes use of data gath-
ering procedures that were formerly only done in diagnos-
tic cardiac catheterization laboratories. Understanding the
relationship between the pressure and blood flow in the
cardiovascular system is the primary reason for perform-
ing hemodynamic monitoring. The cardiovascular system
responds to many and varied stimuli and can be affected by
physical conditioning, drugs, disease, blood loss, injury,
and myocardial insult such as a heart attack. Because of
the complexity of factors controlling the body, it is neces-
sary to make hemodynamic measurements on the system
to understand disease processes and provide optimum
therapy to the patient.
Electrocardiogram
Electrocardiogram (ECG) monitoring is used to determine
heart rate and detect arrhythmias, pacemaker function,
and myocardial ischemia (lack of blood flow to the heart
muscle). To permit optimum ECG monitoring the signal
quality must be excellent (6). Since the ECG electrical
signal from the heart is only 0.5–2.0 mV at the skin’s
surface, it is best measured by properly preparing the skin
and optimally placing the electrodes. Skin can be properly
prepared by removing oil from the surface and abrading













Figure 2. Frank–Starling curve of the heart showing the
ventricular performance (cardiac index) plotted against the end-
diastolic volume typically estimated by using pulmonary artery
wedge pressure. Note to the right of these curves, there is a
pulmonary wedge pressure above which the heart in ineffective
in producing increased flow.
granulosum). In 90% of patients, proper skin preparation
reduces electrode resistance from as high as 200 to as low
as 10 kV. Good electrode placement allows the electrodes to
receive the maximum ECG signal with minimum noise. By
placing the electrodes over bony prominence, such as the
sternum or clavicles, muscle artifact (EMG) can be
reduced. Motion artifact caused by movement of electrodes
can be minimized not only by proper skin preparation, but
also by taping a strain-relieving loop in the lead wires to
prevent movement artifact. Shielded wire on the ECG
leads helps minimizes pickup of alternating current (ac)
electrical fields from 60 Hz power sources, electrosurgical
units, and other sources like radio transmitters. The two
leads that connect the patient form a loop through which
magnetic fields pass and can induce unwanted voltages.
Pickup from magnetic fields can be minimized by decreas-
ing the loop area, by keeping the lead wires close together
(usually twisted pairs), and by avoiding draping the lead
wires over motors, lights, or other electrically powered
instruments.
Electrocardiogram Arrhythmia Monitoring
Early in the development of monitoring techniques, the
application of computer technology to detect patterns of the
electrocardiogram caught the attention of those who
sought to improve care of the critically ill. The computer
appeared to be a logical candidate for relieving the nursing
and medical staff of the tedious chore of continuously
visually monitoring a multichannel oscilloscope.
Arrhythmia monitoring is one of the most sophisticated
of the bedside monitor’s tasks. People-based arrhythmia
monitoring is expensive and unreliable, and those who do it
find the task to be tedious and stressful. Today virtually
every bedside monitor has rhythm monitoring built in.
These monitors use computers and a variety of algorithms
to detect and classify ECG rhythm abnormalities. Classify-
ing these rhythm abnormalities is important to hemody-
namic monitoring since irregular rhythms can cause
dramatic inefficiencies in how the heart works as a pump.
For example, Fig. 3 shows three strip recordings of the
ECG and the corresponding pressure waveform from three
different arrhythmias (ventricular tachycardia, couplet,
which is two beats of abnormal electrical origin, and bige-
miny where every other beat is from abnormal electrical
origin). Note that several of the abnormal beats are hardly
effective at creating any change in the arterial pressure.
Those same beats deliver small stroke volumes to the
patient’s systemic circulation. As a consequence, one can-
not assume that the cardiac output remains constant or
increases just because the heart rate increases.
MEASUREMENTS
Blood Pressure Monitoring
Arterial blood pressure can be measured by both direct and
indirect methods. However, central venous pressure (CVP),
pulmonary artery (PA), and pulmonary capillary wedge
pressure (PCWP) used to estimate left atrial pressure, at
present, can only be measured by direct invasive methods.
Arterial Blood Pressure: Indirect Measurement; Using a
Cuff. Recently, the American Heart Association has
updated its recommendations on accurate ‘‘indirect’’
measures of blood pressure (7). The update reports that
the auscultatory technique with trained observer and
mercury manometer continues to be the method of choice
for measurement of a patient’s blood pressure in a physi-
cian’s office. The report also suggests that hybrid devices
that use electronic transducers rather than mercury have
promise. The report indicates that oscillometric devices can
also be used, but only after careful validation.
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Figure 3. Electrocardiogramandarterialpressurewaveformswith
three different abnormal rhythms. (a) Ventricular tachycardia (VT),
whichoccursduringthelast twobeatsof thestrip. (b)Coupletswhere
twosuccessivebeatshaveanabnormalelectricalorigin. (c) Bigeminy
where every other beat is from an abnormal electrical origin.
Pressures are expressed in millimeters of mercury. For example,
the patient in (a) has a systolic arterial pressure of 109 mmHg,
a diastolic pressure of 53 mmHg, and a mean arterial pressure of
75 mmHg.
Unfortunately, the indirect measurement of arterial pres-
sure has serious limitations for patients in shock usually
signaledby lowbloodpressure.Also, sincevirtuallyall reliable
indirect pressure measurement techniques require cuff infla-
tion, such measurements can only be made intermittently.
Direct Blood Pressure Measurements. The direct mea-
surement of blood pressure allows for continuous and
accurate assessment of blood pressures. Direct and con-
tinuous pressure monitoring allows detection of dangerous
hemodynamic events and provides the information neces-
sary to initiate and regulate patient therapy to prevent
catastrophic events. However, monitoring of pressures
provides valuable information only when it is obtained
in a technically satisfactory manner.
To accomplish direct blood pressure measurements, it is
necessary to inserta catheter directly into thecardiovascular
system (8). This invasive technique has risks that must be
weighted against the benefits that can be obtained. These
risks include, infection, blood loss, insertion site damage and
other factors (9,10). For many patients who are in shock or
who have cardiac disease, the benefits far outweigh the risks.
Formal methods for assessing these risks have been pub-
lished by the Coalition for Critical Care Excellence (11).
Blood pressure can be measured on both the pulmonary
(right heart) and systemic (left heart) sides of the circulatory
system. Measurements of both pulmonary and systemic
parameters yield different and important cardiovascular
status. The CVP reflects the patient’s circulating blood
volume or venous tone, and right atrial and ventricular
pressures (right ventricular preload). To measure the right
atrial pressure accurately a catheter must be placed in a
major vein within the chest or directly in the right atrium.
The CVP values fluctuate about atmospheric pressure. The
level of the right heart is usually taken as the zero reference
point from which all other blood pressures are measured.
The CVP gives an indication of only the function of the right
heart, and not left heart’s performance.
To measure the left atrial pressure, it is necessary to place
a catheter tip through the atrial septum from the right
atrium (usually done only with fluoroscopic control in the
cardiac catheterization laboratory) or estimating it by pla-
cing a pulmonary artery (Swan–Ganz) catheter in the
wedged position by inflating its balloon near the catheter tip.
EQUIPMENT
Components of Direct Pressure Monitoring Systems
The components of a direct blood pressure monitoring
system for critically ill patients are shown in Fig. 4 (6,8).
The components numbered 1–7 in the figure are known as
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Figure 4. The 10 components used to monitor direct blood pressure. The monitoring components
are nearly independent of whether the catheter is in an artery (radial, brachial, or femoral) or in the
pulmonary artery. Size of transducer and plumbing components are enlarged for illustration
purposes. [Reproduced from Ref. 6, with permission.]
the ‘‘plumbing’’ system and must always be sterile because
the fluid contained therein comes in direct contact with the
patient’s blood. Today virtually all of these components are
disposable or single-use items to minimize patient infec-
tion. Components 8–11 in Fig. 4 are used for processing and
displaying pressure waveforms and derived hemodynamic
parameters.
1. Catheter. Arterial and pulmonary artery catheters
provide access to the patient’s blood vessels to
(a) monitor intravascular pressure and (b) provide
a site for samples for blood to allow determination of
blood gas and other laboratory testing parameters.
These catheters are typically placed by the
percutaneous method, either by the Seldinger
‘‘over-the-needle’’ technique or by introducing the
catheter through a needle (8).
2. Sampling stopcock. Stopcock 1 is used as a site for
withdrawing blood for analysis. When filling the
catheter-tubing-transducer system with fluid,
precautions must be taken to be sure all central
switching cavities of the stopcock are filled and that
entrapped air bubbles are removed. Because stop-
cocks are especially vulnerable sources of patient
contamination, these devices must be handled with
extreme care; ports not in active use should be cov-
ered with sterile caps and medical personnel should
never touch open ports of the stopcocks.
3. Pressure tubing. The catheter and stopcock are nor-
mally attached to a continuous flush device and trans-
ducer by noncompliantpressure tubing. Tooptimize the
dynamic response of the catheter-tubing-transducer
system, long lengths of tubing must be avoided.
4. Stopcock 2. This stopcock is usually put in place to
allow disconnection of the flush device and transdu-
cer from the patient when the patient is moved or
when initially filling the system with fluid.
5. Continuous flush device. This device is used not only
when initially filling the pressure monitoring system,
but also to help prevent blood from clotting in the
catheter. These devices provide a ‘‘continuously
flush’’ of fluid at a rate of from 1 to 3 mL 
h1.
6,7. Transducer dome and Pressure transducer. Today
virtually all transducers used for monitoring are
highly reliable, standardized, disposable devices
(12,13).
8. Amplifier system. The output voltage required to
drive an oscilloscope or strip-chart recorder is pro-
vided by an amplifier system inserted between the
transducer and display. Pressure transducer excita-
tion is provided either from a direct current (dc) or ac
source at a voltage of 4–8 V revolutions per second
(rms). Most amplifier systems include low pass filters
that filter out unwanted high frequency signals. Pres-
sure amplifier frequency response should be flat from 0
to 50 Hz to avoid pressure waveform distortion.
9. Oscilloscope. Pressure waveforms are best visualized
on a calibrated oscilloscope or other similar display
panel.
10. Digital processing and display. Digital displays
provide a simple method for presenting quantitative
data from the pressure waveform. They are found
on most modern pressure monitoring equipment.
Systolic, diastolic, and mean pressure are typically
derived from the pressure waveforms.
11. Strip-chart recorders. Frequently, strip-chart recor-
ders are used to document dynamic response char-
acteristics, respiratory variations in pulmonary
artery pressures, and aberrant rhythms and pres-
sure waveforms.
STATIC CALIBRATION
Zeroing and calibrating the transducer are two important
steps in setting up the direct pressure-monitoring system.
Zeroing the Transducer
The accuracy of blood pressure readings depends on estab-
lishing an accurate reference point from which all subse-
quent measurements are made. The patient’s midaxillary
line (right heart level) is the reference point most com-
monly used (14). The zeroing process is used to compensate
for offset caused by hydrostatic pressure differences, offset
in the pressure transducer, amplifier, oscilloscope, recor-
der, and digital displays. Zeroing is accomplished by open-
ing an appropriate stopcock to the atmosphere and aligning
the resulting fluid-air interface with the midaxillary refer-
ence point.
Once the system is zeroed the stopcock can be switched
to allow the patient’s waveform to be displayed. Pulmonary
artery and pulmonary artery wedge pressure are especially
susceptible to improper zeroing and should be measured
only after the zero point has been verified.
Sensitivity Calibration
The sensitivity of most pressure transducers is fixed at
5.0 mV 
V1 of excitation applied per 1 mmHg (0.13 kpa)
and calibrated by the manufacturers to within 1%. This
degree of accuracy is adequate for clinical purposes. As a
consequence standardized transducers need only to be
zeroed to obtain accurate pressure measurements (12,13).
CHECKING DYNAMIC RESPONSE
In the critical care setting, where most hemodynamic
monitoring is carried out, the catheter-tubing-transducer
systems used can usually be characterized as an under-
damped second-order dynamic system analogous, for
example, to a bouncing tennis ball. A second-order dynamic
system can be expressed mathematically by a second-order
differential equation with characteristics determined by
three mechanical parameters: elasticity, mass, and fric-
tion. These same parameters apply to a catheter-tubing-
transducer system where the natural frequency (fn in Hz)
and damping coefficient determine the dynamic charac-
teristics for a catheter-tubing-transducer system. For an
underdamped second-order system fn and define the system’s
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dynamic characteristics. In the clinical setting fn and can be
measured easily and conveniently by using the ‘‘fast-flush’’
method.
Dynamic response characteristics of catheter-tubing-
transducer systems have been defined by two interrelated
techniques. The first technique specifies the frequency
bandwidth and requires that the system frequency
response must be flat up to a given frequency so that a
specified number of harmonics usually 10 of the original
pulse wave can be reproduced without distortion (Fig. 5).
The second technique specifies fn and The plot of fn and
in Fig. 6 has five areas (6,15). If the characteristics of the
catheter-tubing-transducer ‘‘plumbing’’ system fall in the
adequate or optimal area of the graph, the pressure wave-
forms will be adequately reproduced. If the characteristics
fall into one of the remaining three areas, there will be
pressure waveform distortion. Most catheter-tubing-trans-
ducer systems assembled under optimal conditions are
underdamped, but a few fall into the unacceptable areas
of the chart. Methods for optimizing the catheter-tubing-
transducer system components have been outlined (15–20).
In the clinical setting, there are dramatic differences
between each patient setup; therefore it is mandatory to
verify the adequacy of each pressure-monitoring system by
testing them. The testing can be done easily using the fast-
flush technique.
A fast flush is produced by opening the valve of the
continuous flush device, for example, by pulling and
quickly releasing the pigtail valve on a continuous flush
device. The rapid valve closure generates a near square
wave pressure signal from which fn and of the catheter-
tubing-transducer system can be measured.
Once the fast-flush test has been executed two or three
times, the dynamic response characteristics (fn and) can
quickly and easily be determined. Natural frequency fn can
be estimated by measuring the period of each full oscilla-
tion on a strip-chart recorder following a fast flush (Fig. 7a)
and calculating the frequency from the period. Damping
coefficient can be determined by using the amplitudes of
any two successive peak-to-peak values measured after a
fast flush. The amplitude ratio is calculated by dividing the
measured height of the smaller peak-to-peak value by that
of the amplitude of the larger peak-to-peak value (Fig. 7b).
The amplitude ration can then be converted to a damping
coefficient by using the scale in the right side of Fig. 6.
Once fn and have been determined, these data can be
plotted on the graph of Fig. 6 to ascertain the adequacy of
dynamic response. Some bedside monitors and recorders
may compromise the clinical user’s ability to use the fast-
flush technique because the monitors have built-in low-
pass filters. These filters should be expanded to at least 50
Hz or be eliminated.
Several factors lead to poor dynamic responses: (1) air
bubbles in the system usually caused by a poor initial
catheter-tubing-transducer system setup, (2) pressure tub-
ing that is too long, too compliant, or a diameter that is too
small, and (3) pressure transducers that are too compliant.
The best way to enhance the system’s dynamics is to
improve fn.
Invasive pressure monitoring systems have patient
risks, such as a source of infection and air embolism. In
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Figure 5. Family of frequency versus amplitude ratio plots for five
different damping coefficients z and natural frequencies fn of
the plot shown is 10 Hz. When z¼ 0.1, the system is very
underdamped, and when z¼ 2.0, it is overdamped. The dashed
line shows the frequency versus amplitude characteristic
that would occur if the system had a flat frequency response.
Along the frequency axis are plotted the harmonics of the
pressure wave if the heart rate were 120 beats 
min1 (2
beats 
 s1). Note that by the fifth harmonic (10 Hz) if z¼ 0.1 the
true signal would be amplified five times. If z¼ 2.0 there would be
an attenuation to about one-fourth of the amplitude. In both cases
there would be a gross waveform distortion because neither
situation reflects a high fidelity system dynamic response.
Fidelity of the system can be improved by increasing the fn or























































Figure 6. Plot of fn versus z illustrating the five areas into which
catheter-tubing-transducer systems fall. Systems in the optimal
area will reproduce even the most demanding (fast heart rate and
rapid systolic upstroke) arterial or pulmonary artery waveforms
without distortion. Systems in the adequate area will reproduce
most typical patient waveforms with little or no distortion. All
other areas will cause serious and clinically important waveform
distortion. Note the scale on the right can be used to estimate z
from the amplitude ratio determined during fast flush testing (11).
See Fig. 8 for an example of waveforms. [Reproduced from Ref. 6,
with permission.]
dynamic response and proper zeroing to provide accurate
and reliable data. Merely looking at pressure waveforms
will not provide the information required to determine the
adequacy of the system’s dynamic response (see Fig. 8). Fast-
flush testing to determine these parameters is essential.
SIGNAL AMPLIFICATION, PROCESSING, AND DISPLAY
Once the pressure signal has been transmitted to the trans-
ducer, the bedside monitor operates on that signal. Most
monitors not only display the heart rate and systolic, dia-
stolic,andmeanpressure, but they alsodisplaytheprocessed
waveformon an oscilloscopeand provideananalog output for
a recorder or for transmission to a central display.
Placement of the Pulmonary Artery Catheter
The balloon-tipped, flow-directed, pulmonary artery cathe-
ter (Swan–Ganz) came into widespread use in 1970 (21).
The follow-up development by Ganz of a practical thermal
dilution attachment to the pulmonary artery catheter
permitted convenient and easy measurement of cardiac
output (22). Since these early developments with the
Swan–Ganz catheter, the pulmonary artery catheter has
been fitted with optical fibers which allow measurement of
mixed venous oxygen saturation (23).
The pulmonary artery catheter is inserted into the right
side of the circulation using the percutaneous technique
typically using entry from either the internal jugular or the
subclavian vein. The catheter is floated into the pulmonary
artery without use of fluoroscopy, using the hemodynamic
pressure waveforms as a guide (Fig. 9).
Accurate Measurement of Pulmonary Artery Pressure.
Since it was introduced, the balloon-tipped, flow-directed,
pulmonary artery catheter (Swan–Ganz) has been widely













Figure 7. Measuring dynamic response parameters from the fast-
flush waveform, (a) The natural frequency fn can be determined by
using a strip-chart recording to measure the period of one full
oscillation, as shown. In this example, one full cycle is 2 mm and
at a paper speed of 25 mm 
 s1 this results in fn¼12.5 Hz¼
25 mm 
 s1/2 mm. (b) Determining the damping coefficient z
required measuring two successive peak-to-peak values of the
resulting oscillations. The amplitude ratio of the two successive
peaks is taken, giving a value of 0.58¼13/22.5. With use of the
amplitude ratio and the scale on the right side of Fig. 6, the
damping coefficient z¼ 0.17. Plotting the natural frequency and
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Figure 8. Arterial pressure waveforms were obtained from the
same patient. Shown are Systolic/Diastolic and Mean Pressure
(MP). In panel the (a) Patient’s actual arterial pressure waveform
as if recorded with a catheter-tipped transducer is shown, (b)
shown the same patient’s arterial waveform recorded with an
overdamped system (z¼3.5). Note the fast-flush signal (upper
left) returns slowly to the patient waveform. Systolic pressure is
underestimated, diastolic pressure is overestimated, and MP is
unchanged, (c)Anunderdampedcondition (z¼ 0.1)with low fn¼7Hz.
After the fast flush, the pressure signal oscillates rapidly (rings).
Systolic pressure is overestimated, diastolic is slightly under-
estimated, and MP is correct, (d) shows an underdamped condition
(z¼ 0.15), but with high fn¼25 Hz. The pressure waveform is slightly
distorted and systolic, diastolic, and mean pressures are close to the
actual pressures, (e) shown an ideally damped pressure monitoring
system (z¼0.5). The undershoot after the fast flush is small and the
original patient waveform is adequately reproduced. [Reproduced
from Ref. 6, with permission.]
usually inserted may lead one to conclude that the measure-
ments of pulmonary artery and wedge pressure (PCWP) are
easily and reliably measured. However, such is not the case.
Pulmonary artery pressures can be measured accu-
rately only if the following steps are taken (24–27):
1. The monitor is properly zeroed.
2. Strip-chart recordings of all PA pressures for a time
period covering at least three respiratory cycles are
obtained. Using only the monitor’s digital displays is
insufficient.
3. Dynamic response testing (fast flush) should be
obtained when the catheter is in each position (i.e.,
wedge and PA). If the dynamic response is not
adequate, the problems with the catheter-tubing-
transducer system must be resolved before accurate
pressures can be measured.
4. Pressures (i.e., systolic, diastolic, and mean pres-
sures) should be assessed from a monitor’s display
or a strip-chart recording. The pressure measures
should be made at the end expiration when the
transmural pressure is nearest zero.
CARDIAC OUTPUT DETERMINATION
Cardiac output is the volume of blood ejected by the heart
every minute. Cardiac output is a helpful measurement
since it can be used to evaluate the overall cardiac status of
the critically ill patient, as well as help make the diagnosis
of cardiovascular disease. Ideally a cardiac output
measurement system would be continuous, automatic,
minimally invasive, accurate, fast, inexpensive, and easy
to use clinically. The most common method used to mea-
sure cardiac output in critically ill patients is still the
indicator dilution method. The pulmonary artery catheter
(Swan–Ganz) introduced in the 1970s revolutionized the
ease with which cardiac output could be measured.
The thermal dilution method requires injection of cold
physiological solution, usually normal saline, into the
superior vena cava or right atrium. Cardiac output is
determined by measuring the area under the time–
temperature curve measured in the pulmonary artery
that results from the injection of the cold solution.
The thermal dilution method for determining cardiac
output relies on several assumptions that are not always
correct. First, the exact amount of thermal indicator
injected cannot be quantitated precisely. Second, indicator
is lost at various stages and this loss of indicator (heat loss)
leads to errors.
A block diagram of the thermal dilution measuring
system with typical thermal dilution curves and time of
injection indicated are shown in Fig. 10. Figure 10c and d
show the transit time for the cooled blood moving from the
injection site in the right atrium to the pulmonary artery
measurement site. Calculation of cardiac output requires
measuring the area under the curve. Consequently, a
baseline temperature must be established before the injec-
tion. In turn, the end point is usually determined by
extrapolating to the baseline temperature.
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Figure 9. Composite illustration showing normal pressure waveforms obtained as a fiber optic
balloon flotation pulmonary artery catheter (Swan-Ganz) is advanced from the right atrium to the
pulmonary artery wedge position. [From Daily and Tilkian in Reading List (1986), with permission.]
To ensure that accurate thermal dilution cardiac output
results are obtained, it is recommended that the thermal
dilution curves be presented on a monitoring screen or on a
strip-chart recorder. Studies have shown that synchroniz-
ing the injections with the respiratory cycle improves the
technique’s reproducibility (28). Since there is considerable
variability in cardiac output between measures, at least
three reproducible curves are usually obtained. Averaging
the findings from these three curves gives a more repre-
sentative assessment of cardiac output.
In recent times, the complexities of using the Swan–
Ganz pulmonary artery catheter have result in controver-
sies. Some clinicians feel that such systems should only be
used only when needed and then only sparingly while
others have a differing viewpoint (29,30). Still others have
questioned the ability of making accurate central venous
and pulmonary artery occlusion pressures and whether it
matters (26,27). Many of those issues will be resolved in the
future when there might be better methods for measuring
hemodynamic parameters. Until that time, physicians and
nurses caring for critically ill patients who require hemo-
dynamic monitoring should be aware of several how to
oriented publications (31–34).
Alarming Based on Hemodynamic Parameters. Clinical
hemodynamic monitoring is now several decades old.
What started from a simple beginning has since seen
many dramatic changes in both the development of new
medical devices and skills of the clinicians to use those
devices. However, it is my feeling that we are not yet at
optimum hemodynamic monitoring. Some recent publi-
cations on the topic are illustrative. Sander and collea-
gues in Germany have recently looked at categories of
patients with elevated heart rates who are at higher risk
of cardiac complications (35). Their work resulted in an
editorial comment Vital are vital signs (36). Additional
recent work at Vanderbilt University indicates that
volatility in vital signs is a good predictor of death in
trauma patients (37). Finally, the problem of false
alarms continues to be a huge problem with current
bedside monitors. As part of a Master of Science thesis
in Medical Informatics at the University of Utah, an
investigator found that only about one-third of the stan-
dard alarms for patients in a variety of ICU care were
true alarms. Thus about two-thirds of the alarms are
false. However, if the alarming system used heart rates
determined from both the ECG and the Arterial Blood
Pressure, the number of alarms decreased by  50% and
the false alarm rate was only  25% (38). Having smar-
ter and better hemodynamic monitoring with better and
smarter alarming systems will be crucial for to future
monitoring systems.
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Figure 10. Schematic diagram of the
thermal dilution measurement of cardiac
output. A recorder of some type should
always be used to verify the quality of
the thermal dilution curve, (a) shows the
thermal dilution catheter placed into the
pulmonary artery. Note the location of
injection site and thermistor, (b) shows the
connection of the thermal dilution catheter
connected to a cardiac output processor and
recorder, (c) shows a typical temperature-
time plot sensed by the thermistor near the
catheter tip after an iced saline injection.
The cardiac output determined in this case
was 4.36 L 
min1. (d) Shows a similar
temperature–time plot for a patient with
low cardiac output (2.18 L 
min1). Note
the larger area and broader dispersion of
the waveform caused by the lower flow.
[Reproduced from Ref. 9, with permission.]
COMPUTERIZED DECISION SUPPORT
Much has been learned about hemodynamic measure-
ments and how to use the data to calculate derived patient
parameters. These parameters can then be used to
determine patient status and augment patient therapy
(39–42).
Using hemodynamic data available from bedside moni-
tors and combining that data, in a structured and coded
electronic patient record allows for optimal computerized
decision support (42–44). Morris and his colleagues have
stated the value of computerized decision support well (45).
Only adequately explicit protocols contain enough detail to
lead different clinicians to the same decision when faced
with the same clinical scenario. Guidelines of care provide
only general guidance to patient care and require clinicians
considerable latitude in which care decision should be
made. Computerized protocols, on the other hand, can be
patient-specific and evidence based (46). Using computer-
ized decision-support tools variation in clinical practice can
be reduced and favorable effects on improve patient out-
comes can be accomplished (45,46).
FUTURE
There are still needs for improvement in hemodynamic
monitoring. Being able to make the measurements con-
tinuously, less invasively, and more reliably are areas
where progress is needed. Clearly, using computer aided
decision-support technology to help reduce false alarms
and to guide clinicians in making better patient diagnosis
and more timely and more optimal and effective treatment
decision offer ample opportunity for future research and
progress.
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